Cytokines differentially regulate the synthesis of prostanoid and nitric oxide mediators in tumorigenic versus non-tumorigenic mouse lung epithelial cell lines

Carcinogenesis

Volumn 26, Issue 7, 2005, Pages 1196-1206

  Dwyer Nield, Lori D ^a   Srebernak, Mary C ^a   Barrett, Bradley S ^a   Ahn, Jinhee ^a   Cosper, Pippa ^a   Meyer, Amy M ^a   Kisley, Lori R ^a   Bauer, Alison K ^a   Thompson, David C ^a   Malkinson, Alvin M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; CYCLOOXYGENASE 2; CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NITRIC OXIDE; PROSTACYCLIN; PROSTAGLANDIN E2; PROSTANOID; TUMOR NECROSIS FACTOR ALPHA; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; PROSTAGLANDIN;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CARCINOGENESIS; CELL LINE; CELL TRANSFORMATION; CHEMICAL CARCINOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; CYTOKINE RELEASE; ENZYME INHIBITION; ENZYME SYNTHESIS; EPITHELIUM CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR CELL LINE; ANIMAL; COMPARATIVE STUDY; CYTOLOGY; IMMUNOLOGY; LUNG; LUNG TUMOR; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; EPITHELIAL CELLS; INFLAMMATION; LUNG; LUNG NEOPLASMS; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDINS;

EID: 22844440339     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi061     Document Type: Article

References (70)

1. Robbins,R.A. and Rennard,S.I. (1997) Biology of airway epithelial cells. In Crystal,R.G., West,J.A.B., Weibel,E.R. and Barnes,P.J. (eds) The Lung. Lippincott, Philadelphia, pp. 445-458.
2. Wu,A.H., Fontham,E.T., Reynolds,P., Greenberg,R.S., Buffler,P., Liff,J., Boyd,P., Henderson,B.E. and Correa,P. (1995) Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am. J. Epidemiol., 141, 1023-1032.
3. Cohen,B.H., Diamond,E.L., Graves,C.G., Kreiss,P., Levy,D.A., Menkes,H.A., Permutt,S., Quaskey,S. and Tockman,M.S. (1977) A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet, 2, 523-526.
4. Duperron,C. and Castonguay,A. (1997) Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. Carcinogenesis, 18, 1001-1006.
5. Keith,R.L., Miller,Y.E., Hoshikawa,Y., Moore,M.D., Gesell,T.L., Gao,B., Malkinson,A.M., Golpon,H.A., Nemenoff,R.A. and Geraci,M.W. (2002) Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer. Cancer Res., 62, 734-740.
6. Kisley,L.R., Barrett,B.S., Bauer,A.K., Dwyer-Nield,L.D., Barthel,B., Meyer,A.M., Thompson,D.C. and Malkinson,A.M. (2002) Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis. Cancer Res., 62, 6850-6856.
7. Ballaz,S. and Mulshine,J.L. (2003) The potential contributions of chronic inflammation to lung carcinogenesis. Clin. Lung Cancer, 5, 46-62.
8. Malkinson,A.M. (2004) Role of inflammation in mouse lung tumorigenesis: a review. Exp. Lung Res., 31, 57-82.
9. Arenberg,D.A., Keane,M.P., DiGiovine,B., Kunkel,S.L., Strom,S.R., Burdick,M.D., Iannettoni,M.D. and Strieter,R.M. (2000) Macrophage infiltration in human non-small-cell lung cancer: The role of CC chemokines. Cancer Immunol. Immunother., 49, 63-70.
10. Bauer,A.K., Malkinson,A.M. and Kleeberger,S.R. (2004) Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: Genetic similarities. Am. J. Physiol., 287, L685-L703.
11. 2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J. Biol. Chem., 277, 50828-50833.
12. Heasley,L.E., Thaler,S., Nicks,M., Price,B., Skorecki,K. and Nemenoff,R.A. (1997) Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer. J. Biol. Chem., 272, 14501-14504.
13. Narumiya,S. and FitzGerald,G.A. (2001) Genetic and pharmacological analysis of prostanoid receptor function. J. Clin. Invest, 108 25-30.
14. Majima,M., Hayashi,I., Muramatsu,M., Katada,J., Yamashina,S. and Katori,M. (2000) Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br. J. Pharmacol., 130 641-649.
15. Niki,T., Kohno,T., Iba,S. et al. (2002) Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas. Am. J. Pathol., 160, 1129-1141.
16. Huang,M., Stolina,M., Sharma,S., Mao,J.T., Zhu,L., Miller,P.W., Wollman,J., Herschman,H. and Dubinett,S.M. (1998) Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: Up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res., 58 1208-1216.
17. Sanchez-Alcazar,J.A., Bradbury,D.A., Pang,L. and Knox,A.J. (2003) Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways. Lung Cancer, 40, 33-44.
18. Hanahan,D. and Weinberg,R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70.
19. Cronstein,B.N., Kimmel,S.C., Levin,R.I., Martiniuk,F. and Weissmann,G. (1992) A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc. Natl Acad. Sci. USA, 89, 9991-9995.
20. Moody,T.W., Leyton,J., Zakowicz,H. et al. (2001) Indomethacin reduces lung adenoma number in A/J mice. Anticancer Res., 21 1749-1755.
21. Gunning,W.T., Kramer,P.M., Lubet,R.A., Steele,V.E. and Pereira,M.A. (2000) Chemoprevention of vinyl carbamate-induced lung tumors in strain A mice. Exp. Lung Res., 26, 757-772.
22. Kisley,L.R., Barrett,B.S., Dwyer-Nield,L.D., Bauer,A.K., Thompson,D.C. and Malkinson,A.M. (2002) Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice. Carcinogenesis, 23, 1653-1660.
23. Tegeder,I., Pfeilschifter,J. and Geisslinger,G. (2001) Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J., 15, 2057-2072.
24. Bernert,H., Sekikawa,K., Radcliffe,R.A., Iraqi,F., You,M. and Malkinson,A.M. (2003) Tnfa and Il-10 deficiencies have contrasting effects on lung tumor susceptibility: Gender-dependent modulation of IL-10 haploinsufficiency. Mol. Carcinog., 38, 117-123.
25. 2. Carcinogenesis, 25, 1517-1524.
26. Hoeper,M.M., Schwarze,M., Ehlerding,S., Adler-Schuermeyer,A., Spiekerkoetter,E., Niedermeyer,J., Hamm,M. and Fabel,H. (2000) Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N. Engl. J. Med., 342, 1866-1870.
27. Williams,T.J. and Peck,M.J. (1977) Role of prostaglandin-mediated vasodilatation in inflammation. Nature, 270, 530-532.
28. Downey,G.P., Gumbay,R.S., Doherty,D.E., LaBrecque,J.F., Henson,J.E., Henson,P.M. and Worthen,G.S. (1988) Enhancement of pulmonary inflammation by PGE2: Evidence for a vasodilator effect. J. Appl. Physiol, 64, 728-741.
29. Perez-Sala,D. and Lamas,S. (2001) Regulation of cyclooxygenase-2 expression by nitric oxide in cells. Antioxid. Redox. Signal., 3, 231-248.
30. Salvemini,D. (1997) Regulation of cyclooxygenase enzymes by nitric oxide. Cell Mol. Life Sci., 53, 576-582.
31. Bauer,A.K., Dwyer-Nield,L.D. and Malkinson,A.M. (2000) High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. Carcinogenesis, 21, 543-550.
32. Malkinson,A.M., Dwyer-Nield,L.D., Rice,P.L. and Dinsdale,D. (1997) Mouse lung epithelial cell lines-tools for the study of differentiation and the neoplastic phenotype. Toxicology, 123, 53-100.
33. Barnes,P.J. (2003) Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine Growth Factor Rev., 14, 511-522.
34. Robbins,R.A., Springall,D.R., Warren,J.B., Kwon,O.J., Buttery,L.D., Wilson,A.J., Adcock,I.M., Riveros-Moreno,V., Moncada,S. and Polak,J. (1994) Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem. Biophys. Res. Commun., 198, 835-843.
35. Belvisi,M.G., Saunders,M.A., Haddad,E.L., Hirst,S.J., Yacoub,M.H., Barnes,P.J. and Mitchell,J.A. (1997) Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: Novel inflammatory role of this cell type. Br. J. Pharmacol., 120, 910-916.
36. Bentel,J.M., Lykke,A.W. and Smith,G.J. (1989) Cloned murine non-malignant, spontaneously transformed and chemical tumour-derived cell lines related to the type 2 pneumocyte. Cell Biol. Int. Rep., 13, 729-738.
37. Parsa,I. and Kauffman,S.L. (1983) Malignant Clara cell line derived from ethylnitrosourea-induced murine lung adenomas. Cancer Lett., 18 311-316.
38. Brash,A.R., Jackson,E.K., Saggese,C.A., Lawson,J.A., Oates,J.A. and FitzGerald,G.A. (1983) Metabolic disposition of prostacyclin in humans. J. Pharmacol. Exp. Ther., 226, 78-87.
39. Malkinson,A.M. and Beer,D.S. (1983) Major effect on susceptibility to urethan-induced pulmonary adenoma by a single gene in BALB/cBy mice. J. Natl Cancer Inst., 70, 931-936.
40. Hybertson,B.M., Dunham,A.J., Thompson,D.C., Terada,L.S. and Repine,J.E. (1994) Flow injection analysis of nitrite generated by neutrophils and endothelial cells. Anal. Lett., 27, 3081-3093.
41. Lowry,O.H., Rosebrough,N.J., Farr,A.L. and Randall,R.J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem., 193 265-275.
42. Thompson,D.C., Porter,S.E., Bauer,A.K., Das,K.C., Ou,B., Dwyer-Nield,L., White,C.W. and Malkinson,A.M. (1998) Cytokine-induced nitric oxide formation in normal but not in neoplastic murine lung epithelial cell lines. Am. J. Physiol., 274, L922-L932.
43. Misko,T.P., Moore,W.M., Kasten,T.P., Nickols,G.A., Corbett,J.A., Tilton,R.G., McDaniel,M.L., Williamson,J.R. and Currie,M.G. (1993) Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol., 233, 119-125.
44. Blaine,S.A., Meyer,A.M., Hurteau,G., Wick,M., Hankin,J.A., Murphy,R.C., Dannenberg,A.J., Geraci,M.W., Subbaramaiah,K. and Nemenoff,R.A. (2005) Targeted over-expression of mPGES-1 and elevated PGE2 production is not sufficient for lung tumorigenesis in mice. Carcinogenesis, 26 209-217.
45. Hubbard,W.C., Alley,M.C., Gray,G.N., Green,K.C., McLemore,T.L. and Boyd,M.R. (1989) Evidence for prostanoid biosynthesis as a biochemical feature of certain subclasses of non-small cell carcinomas of the lung as determined in established cell lines derived from human lung tumors. Cancer Res., 49, 826-832.
46. 2 receptor (EP2). Proc. Am. Assoc. Cancer Res., 44, 902.
47. Stearman,R.S., Dwyer-Nield,L.D., Zerbe,L., Malkinson,A.M. and Geraci,M. (2004) Expression analysis in lung cancer: The search for biomarkers. Am. J. Respir. Cell Mol. Biol., 31, S39-S43.
48. McLemore,T.L., Hubbard,W.C., Litterst,C.L., Liu,M.C., Miller,S., McMahon,N.A., Eggleston,J.C. and Boyd,M.R. (1988) Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients. Cancer Res., 48, 3140-3147.
49. Kwon,S., Newcomb,R.L. and George,S.C. (2001) Mechanisms of synergistic cytokine-induced nitric oxide production in human alveolar epithelial cells. Nitric Oxide, 5, 534-546.
50. Marrogi,A.J., Travis,W.D., Welsh,J.A. et al. (2000) Nitric oxide synthase, cyclooxygenase 2 and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin. Cancer Res., 6, 4739-4744.
51. Liu,C.Y., Wang,C.H., Chen,T.C., Lin,H.C., Yu,C.T. and Kuo,H.P. (1998) Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. Br. J. Cancer, 78, 534-541.
52. Xu,W., Liu,L.Z., Loizidou,M., Ahmed,M. and Charles,I.G. (2002) The role of nitric oxide in cancer. Cell Res., 12, 311-320.
53. Maeda,H., Noguchi,Y., Sato,K. and Akaike,T. (1994) Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn. J. Cancer Res., 85, 331-334.
54. Kubes,P. and Granger,D.N. (1992) Nitric oxide modulates microvascular permeability. Am. J. Physiol., 262, H611-H615.
55. Pan,Y.H., Nuzum,E.O., Hanson,L.A. and Beer,D.G. (1990) Ki-ras activation and expression in transformed mouse lung cell lines. Mol. Carcinog. 3, 279-286.
56. Watkins,D.N., Garlepp,M.J. and Thompson,P.J. (1997) Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide. Br. J. Pharmacol., 121, 1482-1488.
57. Hamilton,L.C. and Warner,T.D. (1998) Interactions between inducible isoforms of nitric oxide synthase and cyclo-oxygenase in vivo: investigations using the selective inhibitors, 1400 W and celecoxib. Br. J. Pharmacol., 125, 335-340.
58. Kosaka,T., Miyata,A., Ihara,H., Hara,S., Sugimoto,T., Takeda,O., Takahashi,E. and Tanabe,T. (1994) Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur. J. Biochem., 221, 889-897.
59. Xie,Q.W., Whisnant,R. and Nathan,C. (1993) Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J. Exp. Med. 177, 1779-1784.
60. Shakhov,A.N., Collart,M.A., Vassalli,P., Nedospasov,S.A. and Jongeneel,C.V. (1990) Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J. Exp. Med., 171, 35-47.
61. Hwang,D., Jang,B.C., Yu,G. and Boudreau,M. (1997) Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-kappaB signaling pathways in macrophages. Biochem. Pharmacol., 54, 87-96.
62. Lee,J.K., Choi,S.S., Won,J.S. and Suh,H.W. (2003) The regulation of inducible nitric oxide synthase gene expression induced by lipopolysaccharide and tumor necrosis factor-alpha in C6 cells: involvement of AP-1 and NFkappaB. Life Sci., 73, 595-609.
63. Oeth,P. and Mackman,N. (1995) Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells. Blood, 86, 4144-4152.
64. Hermoso,M.A. and Cidlowski,J.A. (2003) Putting the brake on inflammatory responses: The role of glucocorticoids. IUBMB Life, 55, 497-504.
65. Gilroy,D.W., Colville-Nash,P.R., Willis,D., Chivers,J., Paul-Clark,M.J. and Willoughby,D.A. (1999) Inducible cyclooxygenase may have antiinflammatory properties. Nature Med., 5, 698-701.
66. Smyth,E.M., Austin,S.C., Reilly,M.P. and FitzGerald,G.A. (2000) Internalization and sequestration of the human prostacyclin receptor. J. Biol. Chem., 275, 32037-32045.
67. Liu,C.H., Chang,S.H., Narko,K., Trifan,O.C., Wu,M.T., Smith,E., Haudenschild,C., Lane,T.F. and Hla,T. (2001) Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J. Biol. Chem., 276, 18563-18569.
68. Kamei,D., Murakami,M., Nakatani,Y., Ishikawa,Y., Ishii,T. and Kudo,I. (2003) Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis. J. Biol. Chem., 278, 19396-19405.
69. Bol,D.K., Rowley,R.B., Ho,C.P., Pilz,B., Dell,J., Swerdel,M., Kiguchi,K., Muga,S., Klein,R. and Fischer,S.M. (2002) Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development. Cancer Res., 62, 2516-2521.
70. 2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. J. Immunol., 157, 5512-5520.